Aspirin for Prevention of Venous Thromboembolism Among Ovarian Cancer Patients Receiving Neoadjuvant Chemotherapy
Status:
Recruiting
Trial end date:
2021-12-30
Target enrollment:
Participant gender:
Summary
This is a pilot study to determine the safety and efficacy of low dose aspirin for the
prevention of venous thromboembolism among women with advanced ovarian cancer receiving
neoadjuvant chemotherapy.